We bring you the latest on mental health research at the National Centre for Mental Health (NCMH) and the Centre for Neuropsychiatric Genetics and Genomics at Cardiff University, plus real-life experiences of people affected by mental health problems.
We would love to hear your feedback or ideas for future episodes, either comment on our latest episode, message us at info@ncmh.info or include #POMpod in our social media posts.
Darn o Feddwl: Iechyd Meddwl a Seiciatreg
Rydym yn rhannu'r diweddaraf ar ymchwil iechyd meddwl yn y Ganolfan Iechyd Meddwl Genedlaethol (NCMH) a'r Ganolfan Geneteg a Genomeg Niwroseiciatrig ym Mhrifysgol Caerdydd, a phrofiadau bywyd go iawn pobl sy'n cael eu heffeithio gan broblemau iechyd meddwl.
Byddem wrth ein bodd yn clywed eich adborth neu syniadau ar gyfer penodau yn y dyfodol: naill ai rhowch sylwadau ar ein pennod ddiweddaraf, anfonwch neges atom yn info@ncmh.info neu gynnwys #POMpod yn ein postiadau cyfryngau cymdeithasol.
Hosted on Acast. See acast.com/privacy for more information.
We bring you the latest on mental health research at the National Centre for Mental Health (NCMH) and the Centre for Neuropsychiatric Genetics and Genomics at Cardiff University, plus real-life experiences of people affected by mental health problems.
We would love to hear your feedback or ideas for future episodes, either comment on our latest episode, message us at info@ncmh.info or include #POMpod in our social media posts.
Darn o Feddwl: Iechyd Meddwl a Seiciatreg
Rydym yn rhannu'r diweddaraf ar ymchwil iechyd meddwl yn y Ganolfan Iechyd Meddwl Genedlaethol (NCMH) a'r Ganolfan Geneteg a Genomeg Niwroseiciatrig ym Mhrifysgol Caerdydd, a phrofiadau bywyd go iawn pobl sy'n cael eu heffeithio gan broblemau iechyd meddwl.
Byddem wrth ein bodd yn clywed eich adborth neu syniadau ar gyfer penodau yn y dyfodol: naill ai rhowch sylwadau ar ein pennod ddiweddaraf, anfonwch neges atom yn info@ncmh.info neu gynnwys #POMpod yn ein postiadau cyfryngau cymdeithasol.
Hosted on Acast. See acast.com/privacy for more information.
We’re delighted to be joined by Dr Sophie Legge and Dr Antonio Pardiñas for our latest minisode to discuss their latest research study.
Sophie, Antonio and colleagues at Cardiff University’s MRC Centre for Neuropsychiatric Genetics and Genomics examined genetic data from more than 500 people of African descent taking clozapine, an anti-psychotic medication prescribed to people with treatment resistant schizophrenia.
Clozapine is currently the most effective treatment for people with treatment-resistant schizophrenia, but it can cause a rare side effect called neutropenia. In the most extreme cases, this can develop into agranulocytosis; a severe and potentially life-threatening condition.
These side-effects are characterised by lower neutrophil levels, a type of white blood cell, and these lower levels appear to be more common in people of African descent. The team were interested in learning whether genetic factors were at play, and in this minisode Sophie and Antonio explain what they found and how their results could help improve the management of clozapine treatment.
For links and resources mentioned in this episode, visit https://www.ncmh.info/podcast
We hope you enjoy and we would be really grateful if you could leave us a review and help others find our podcast! If you've got any questions about this episode, get in touch at info@ncmh.info.
Hosted on Acast. See acast.com/privacy for more information.